Posts Tagged ‘dysport’

Uses for Botox and Dysport Continue to Grow

Sunday, March 6th, 2011

Before and after Botox

Botulinum toxin type A, which includes Botox and Dysport, was the top non-surgical cosmetic procedure of 2010, according to recent stats from the American Society of Plastic Surgeons (ASPS). These injectables have proven their popularity and effectiveness as wrinkle fillers, and the companies that make them continue to look to expand their usage.

A CBS Interactive Business Network report gives an update on what the future may hold for these products. Medicis, maker of Dysport, is working with a company called Revance to create a wipe-on, wipe-off version of botulinum toxin to treat facial wrinkles and excessive sweating.

Meanwhile Allergan, maker of Botox, is researching the drug for several uses, which include as a painkiller and a treatment for juvenile cerebral palsy and enlarged prostate.

Allergan also continues to focus on Botox’s huge success as a wrinkle filler with a new website that allows users to upload their own photos. Then they can manipulate the image to see what they might look like after Botox (pictured in this post is an example of a before and after image from the website).

Botox was also approved in October 2010 as a preventive treatment for chronic migraine.

The CBS report says sales of Allergan’s Botox began recovering last year after declining during the recession, and ASPS statistics show that cosmetic minimally-invasive procedures increased 5 percent in 2010 from 2009.

Dysport, which was released by Medicis in 2009, has also seen sales success. The company’s non-acne skin products were up 31 percent in 2010, and most of that increase was attributed to Dysport.

Dr. Heffernan offers same day appointments for Botox and Dypsort.

Dysport Gives Patients Quick Results

Saturday, November 6th, 2010

Dysport logoDysport and Botox, which are both offered by Dr. J. Timothy Heffernan in Seattle, are famous for their ability to temporarily reduce glabellar lines— known as frown lines—which appear on the smooth part of a person’s forehead, between and above the eyebrows. While both are effective, a new study indicates that Dysport may work up to two days sooner than Botox.

Cosmetic surgeon Dr. Joel Schlessinger presented his findings at the American Society for Dermatologic Surgery 2010 Annual Meeting; the results were of a subset analysis of a phase 3 clinical trial designed to evaluate the effectiveness of Dysport.

An analysis of the Dysport group (n = 1160) showed that 19.7 percent of the participants responded to Dysport on day one. Three days was the median response time to the Dysport treatment.

Dr. Schlessinger said, “There are many different neurotoxins out there, and they have different types of effects on the injected individual, depending on the physical and molecular makeup of the neurotoxin.” He went on to say that Dysport appears to take effect slightly faster than Botox, by about two days. “That can be very helpful for a person who is looking for a faster onset, especially if [he or she] has a social function coming up,” he added.

The “study … validates what clinicians have observed clinically with the use of [Dysport] with regard to its early onset of action in many patients,” said Dr. Elliot Weiss from the Laser and Skin Surgery Center of New York in New York City.

New Report Says Cosmetic Surgery Market to Grow to Over $3 Billion by 2017

Tuesday, September 21st, 2010

Woman receiving facial injectionThe cosmetic surgery, facial aesthetics and medical lasers market is expected to double in size by 2017, exceeding $3 billion, according to a new report by by iData Research, a medical device and pharmaceutical market research company.

The report estimated that the market for Botox and Dysport, botulinum toxin-A injectables, is estimated to grow to $543 million by 2017. It also anticipated that the aesthetic laser and light therapy markets for skin resurfacing, hair removal, and laser lipolysis will  be the fastest growing cosmetic procedure markets in the next seven years.

Dr. Kamran Zamanian, CEO of iData, had this to say: “Allergan has had a monopoly on botulinum toxin A drugs since 2002, but now faces competition from Dysport(R) by Medicis as well as other new competitors expected to enter the market. Allergan and Medicis have been fierce rivals, as their Juvederm and Restylane facial dermal fillers compete in the lucrative dermal filler market.”

The report also said that competition in the botulinum toxin market will further intensify with expected newcomer PurTox by Mentor. According to Mentor, PurTox is in Phase III clinical trials in the U.S.

The use of botulinum toxins is also expected to increase due to a growing number of therapeutic treatments that go beyond filling wrinkles. “A growing number of doctors are looking at the therapeutic potential of Botulinum-A. There are more cosmetic procedures performed using Botulinum-A than therapeutic, however therapeutic procedures use higher doses of the drug, therefore these two markets are similar in value,” says Dr. Zamanian.

Currently the U.S. injectables market for is valued around $860 million, according to the report “Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011,” which includes data, analyses, and competitor profiles for botulinum toxins, dermal fillers, breast augmentation implants, liposuction aspirators, laser/light devices, and microdermabrasion.

Now’s the Time to Try Dysport and Save Money Trying It

Monday, August 9th, 2010

Frown lines injectionIt’s the perfect time to try Dysport if you’ve been considering it for your frown lines because the Dysport Challenge—going on through September—could save you up to $150. Since the challenge started in March over 100,000 patients have registered for the challenge, according to Medicis, maker of Dysport.

The way the challenge works is that patients who try Dypsort save $75. After the procedure, if they select that they “love it” they can get a rebate for $75 off their next Dysport injection. If they choose “leave it” then they get a $75 rebate off another get another botulinum toxin type A product, such as Botox.

Over 90 percent of the over 22,000 patients who took the challenge between March 1 and May 9, 2010, chose “love it,” according to Medicis. Less than 3 percent of all registrants have made a selection to “leave it” since the program started.

“We are pleased to announce this tremendous support by both physicians and patients for the Dysport Challenge,” said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis, which also markets dermal fillers Restylane and Perlane. “Medicis made a bold statement of confidence in the brand by offering patients the opportunity to try Dysport and save up to $150 total.”

Approved by the FDA in April 2009, Dysport can treat severe frown lines between the eyebrows and is the first botulinum toxin competitor to Botox in the United States to receive approval. Dysport works much like Botox, using botulinum toxin type A to temporarily relax wrinkles. Dysport blocks the chemical triggers that cause specific facial muscles to contract, which allows wrinkles to flatten out.

The Dysport Challenge is open to patients 18 and older and full details are available at www.DysportUSA.com.

Dr. Heffernan’s Seattle cosmetic surgery practice offers both Dysport and Botox.

Take the Dysport Challenge in Seattle March 1 – April 30

Monday, March 1st, 2010

From March 1 until April 30, 2010, you can save $150 on 2 treatments with Dysport, the latest injectable wrinkle treatment containing botulinum toxin type a.

To take the “Dysport Challenge” you need to register at Dysportusa.com. According to the website, you can download a coupon rebate form within 14 days after your first Dysport treatment to receive a 75 dollar rebate check. If you love Dysport, you can repeat the process and get another rebate after 3 months.

Read more about Dysport with Dr. Heffernan in Seattle

Is There a Perfect Age to Get Botox Cosmetic?

Monday, February 8th, 2010

“I probably don’t need cosmetic surgery – but I could see myself getting Botox when I’m a little bit older,” said my 26-year-old friend over dinner last Friday. I think her opinion is pretty normal, but it begs the question, what age is “old enough” for Botox?

For most people, the appropriate age to get Botox (or Dysport) probably depends on when their frown lines become noticeable and when they have the disposable income to afford the treatment. But does that mean the patient is necessarily middle-aged?

(more…)

New Botox Therapies, Cosmetic Uses Emerging

Friday, May 1st, 2009

Botox has been proven to smooth out facial wrinkles by surgeons worldwide, but that has hardly been the extent of its usage.  If you do a little research, you’ll find that physicians are using Botox for many interesting purposes, and new techniques are emerging all the time.

As reported in the Journal of the American Academy of Dermatology, researchers from Allergan Inc. conducted surveys about sweating, revealing that almost 3 percent of the U.S. population (7.8 million people) believe their sweating to be excessive. At the time of the survey (in 2004), less than half of the respondents had sought medical help for the problem. Botox blocks the localized release of a specific chemical that stimulates sweating, and so the FDA approved it for this use years ago.

Many doctors also routinely use Botox to treat headaches, and their basic procedures are hardly different than those of wrinkle treatment. It isn’t entirely clear how the Botulinum toxin provides relief; it may work to inhibit certain pain-transmitting nerves. Studies have nonetheless shown that people experience fewer headaches after Botox injection.

Last March, the New York Times published a story on the off-label use of Botox to help those who have suffered a stroke and have trouble relaxing certain muscles. According to the experts, “only about 5 percent of the stroke patients who could benefit from its use ever get it.”

Patients with even more obscure conditions have found success using Botox. In Feb 2008, USA Today reported that radio personality Diane Rehm (of National Public Radio) had received routine off-label Botox treatments for a vocal disorder called spasmodic dysphonia.

Aside from these therapies, surgeons and dermatologists are finding even more cosmetic uses for Botox. Dr. Lawrence Reed recently told an ABC news affiliate that “we’re at the tip of the iceberg where Botox is going to be used.” Reed has apparently been pioneering some interesting new cosmetic applications.

For acne, Dr. Reed injects Botox just below the skin: “It decreases the muscle pump and blocks the production of oils, so we use it for acne,” he claims. Other patients of Dr. Reed found success using Botox to relax certain muscles and actually make their eyes appear larger, and to supplement laser skin resurfacing.

If you’re considering Botox for any off-label use, make sure you choose a qualified physician. Despite the optimism surrounding Botox as a ‘wonder drug’, there have been complications and side effects associated with off-label use and inexperienced providers. If you’re interested in Botox treatment around Seattle, see our homepage or contact us.